TrialClinical cancer research : an official journal of the American Association for Cancer Research2026

Efficacy and Safety of Belantamab Mafodotin with Bortezomib plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: The DREAMM-6 Arm B Trial.

Rakesh Popat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.